Pathophysiology of gastro-oesophageal reflux disease (GERD) with respect to reflux-induced carcinogenesis

European Surgery - Acta Chirurgica Austriaca

Volumn 34, Issue 5, 2002, Pages 296-302

  Wykypiel, H ^b   Gadenstatter M ^b   Granderath, F A ^b   Klingler, P J ^b   Wetscher, G J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

Carcinogenesis; Duodenogastric reflux; Free radicals; Gastro oesophageal reflux; Review

Indexed keywords

EPIDERMAL GROWTH FACTOR; GASTRIN RECEPTOR; MUCIN; OMEPRAZOLE; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE;

ANEUPLOIDY; ANTIREFLUX OPERATION; APOPTOSIS; BARRETT ESOPHAGUS; CARCINOGENESIS; CLINICAL FEATURE; DRUG EFFECT; DUODENOGASTRIC REFLUX; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; GASTROTOMY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; QUALITY OF LIFE; RECEPTOR BLOCKING; REVIEW; STOMACH MOTILITY; VAGOTOMY;

EID: 0036968194     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2563.2002.02071.x     Document Type: Review

References (91)

1. Attwood SE: Barrett's esophagus. Curr Opin Gen Surg 1993:180-188.
2. Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA: Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992;111:503-510.
3. Bagchi D, Das DK, Engelman RM, Prasad MR, Subramanian R: Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J 1990;11:800-813.
4. Bagchi M, Hassoun EA, Bagchi D, Stohs SJ. Endrin-induced increases in hepatic lipid peroxidation, membrane microviscosity, and DNA damage in rats. Arch Environ Contam Toxicol 1992;23:1-5.
5. Bagchi M, Hassoun EA, Bagchi D, Stohs SJ: Production of reactive oxygen species by peritoneal macrophages and hepatic mitochondria and microsomes from endrin-treated rats. Free Radic Biol Med 1993;14:149-155.
6. Bagchi M, Stohs SJ: In vitro induction of reactive oxygen species by 2,3,7,8-tetrachlorodibenzo-p-dioxin, endrin, and lindane in rat peritoneal macrophages, and hepatic mitochondria and microsomes. Free Radic Biol Med 1993;14:11-18.
7. Bankson DD, Kestin M, Rifai N: Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993;13:463-480.
8. Bass BL, Trad KS, Harmon JW, Hakki FZ: Capsaicin-sensitive nerves mediate esophageal mucosal protection. Surgery 1991;110:419-425 (discussion 425-426).
9. Bonavina L, Evander A, DeMeester TR, Walther B, Cheng SC, Palazzo L, Concannon JL: Length of the distal esophageal sphincter and competency of the cardia. Am J Surg 1986;151:25-34.
10. Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ: Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 1992;164:522-526 (discussion 526-527).
11. Brown CM, Rees WD: Review article: factors protecting the oesophagus against acid-mediated injury. Aliment Pharmacol Ther 1995;9:251-262.
12. Buege J, Aust S: Microsomal lipid peroxidation. Methods Enzymol 1972;52:302-310.
13. Caldwell MT, Byrne PJ, Brazil N, Crowley V, Attwood SE, Walsh TN, Hennessy TP: An ambulatory bile reflux monitoring system: an in vitro appraisal. Physiol Meas 1994;15:57-65.
14. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR: Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-614.
15. Del Soldato P, Foschi D, Beboni G, Scarpignato C: Oxygen derived free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 1985;17:484-488.
16. DeMeester SR, DeMeester TR: Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-321.
17. DeMeester TR, Wang CI, Wemly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 1980;79:656-670.
18. DeVault KR: Overview of therapy for the extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 2000;95(8 Suppl):S39-S44.
19. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
20. Dodds WJ, Hogan WJ, Helm JF, Dent J: Pathogenesis of reflux esophagitis. Gastroenterology 1981;81:376-394.
21. Eckardt VF: Does healing of esophagitis improve esophageal motor function? Dig Dis Sci 1988;33:161-165.
22. Eckardt VF, Kanzler G, Bernhard G: Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 2001;111:33-37.
23. Fibbe C, Layer P, Keller J, Strate U, Emmermann A, Zornig C: Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 2001;121:5-14.
24. Fiorucci S, Santucci L, Chiucchiu S, Morelli A: Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis [see comments]. Gastroenterology 1992;103:855-861.
25. Gadenstatter M, Klingler A, Klocker H, Wetscher GJ: Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis. Wien Klin Wochenschr 2000;112:70-74.
26. Gadenstatter M, Klingler A, Prommegger R, Hinder RA, Wetscher GJ: Laparoscopic partial posterior fundoplication provides excellent intermediate results in GERD patients with impaired esophageal peristalsis. Surgery 1999;126:548-552.
27. Gadenstatter M, Prommegger R, Klingler A, Schwelberger H, Weiss HG, Glaser K, Wetscher GJ: Alterations of gut neuropeptides in gastroesophageal reflux disease are resolved after antireflux surgery. Am J Surg 2000;180:483-487.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
29. Gillen P, Keeling P, Byme PJ, Hennessy TP: Barrett's oesophagus: pH profile. Br J Surg 1987;74:774-776.
30. Granderath FA, Kamolz T, Schweiger UM, Bammer T, Pointner R: Quality of life and subjective evaluation of outcome quality 3 years after laparoscopic antireflux surgery. Chirurg 2000;71:950-954.
31. Green D, Martin S: The killer and the executioner: How apoptosis controls malignancy. Curr Opin Immunol 1995;7:694-703.
32. Haegele AD, Briggs SP, Thompson HJ: Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage. Free Radic Biol Med 1994;16:111-115.
33. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984;310:284-288.
34. Heyman S, Kirkpatrick JA, Winter HS, Treves S: An improved radionuclide method for the diagnosis of gastroesophageal reflux and aspiration in children (milk scan). Radiology 1979;131:479-482.
35. Hinder RA, Stein HJ: Oxygen-derived free radicals. Arch Surg 1991;126:104-105.
36. Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 1983;118:543-549.
37. Kamolz T, Bammer T, Pasiut M, Pointner R: Health-related and disease-specific quality of life assessment after laparoscopic repeated fundoplication. Chirurg 2000;71:707-711.
38. Kamolz T, Bammer T, Wykypiel H Jr, Pasiut M, Pointner R: Quality of life and surgical outcome after laparoscopic Nissen and Toupet fundoplication: One-year follow-up. Endoscopy 2000;32:363-368.
39. Kamolz T, Wykypiel H Jr, Bammer T, Pointner R: Quality of life after laparoscopic antireflux surgery - Nissen fundoplication. Chirurg 1998;69:947-950.
40. Katada N, Hinder RA, Smyrk TC, Hirabayashi N, Perdikis G, Lund RJ, Woodward T, Klingler PJ: Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg 1997;132:728-733.
41. Kramer EL, Sanger JJ: Esophageal reflux demonstrated on a hepatobiliary scan. Clin Nucl Med 1984;9:161-162.
42. Krausz Y, Maayan C, Faber J, Marciano R, Mogle P, Wynchank S: Scintigraphic evaluation of esophageal transit and gastric emptying in familial dysautonomia. Eur J Radiol 1994;18:52-56.
43. Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH: Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995;175:175-180.
44. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Teijgeman R, Mulder AH, Bosman FT, van Dekken H: Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res 1995;55:1971-1976.
45. Langhans P, Heger RA, Hohenstein J, Schlake W, Bunte H: Operation-sequel carcinoma of the stomach. Experimental studies of surgical techniques with or without resection. World J Surg 1981;5:595-605.
46. Lepoivre M, Flaman JM, Henry Y: Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J Biol Chem 1992;267:22994-3000.
47. Marcinkiewicz M, Han K, Zbroch T: The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease. Am J Gastroenterol 2000;95:1652-1660.
48. Marshall RE, Anggiansah A, Owen WJ: Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997;84:21-28.
49. Mason R, Filipe I: The aetiology of gastric stump carcinoma in the rat. Scand J Gastroenterol 1990;25:961-965.
50. Muldoon DF, Hassoun EA, Stohs SJ: Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon 1992;30:977-984.
51. O'Connor JB, Falk GW, Richter JE: The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999;94:2037-2042.
52. Orlando RC, Bozymski EM: Heartbum in pernicious anemia - a consequence of bile reflux. N Engl J Med 1973;289:522-523.
53. Perdikis G, Wilson P, Hinder R, Redmond E, Wetscher G, Neary P, Adrian T, Quigley E: Altered antroduodenal motility after cholecystectomy. Am J Surg 1994;168:609-614 (discussion 614-615).
54. Perdikis G, Wilson P, Hinder RA, Redmond EJ, Wetscher GJ, Saeki S, Adrian TE: Gastroesophageal reflux disease is associated with enteric hormone abnormalities. Am J Surg 1994;167:186-191 (discussion 191-192).
55. Pihan G, Regillo C, Szabo S: Free radicals and lipid peroxidation in ethanol-or aspirin-induced gastric mucosal injury. Dig Dis Sci 1987;32:1395-1401.
56. Pointner R, Wetscher GJ, Gadenstatter M, Bodner E, Hinder RA: Gastric remnant cancer has a better prognosis than primary gastric cancer. Arch Surg 1994;129:615-619.
57. Sarosiek J, McCallum RW: Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 1995;56(Suppl 1):32-37.
58. Sarosiek J, McCallum RW: What is the secretory potential of submucosal mucous glands within the human gullet in health and disease? Digestion 1995;56(Suppl 1):15-23.
59. Savary M, Miller G: The Esophagus. Handbook and Atlas of Endoscopy. Solothurn, Switzerland, Gassmann AG, 1978.
60. Schwizer W, Hinder RA, DeMeester TR: Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg 1989;157:74-81.
61. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-338.
62. Singh S, Bradley LA, Richter JE: Determinants of oesophageal 'alkaline' pH environment in controls and patients with gastro-oesophageal reflux disease. Gut 1993;34:309-316.
63. Smyrk T: Histology in the diagnosis of foregut disease. In: Hinder R, Nyhus L (eds): Problems in General Surgery. Philadelphia, Lippincott Company, 1992, pp 14-38.
64. Sonnenberg A, Muller-Lissner SA, Weiser HF, Muller-Duysing W, Heinzel F, Blum AL: Effect of liquid meals on duodenogastric reflux in humans. Am J Physiol 1982;243:G42-G47.
65. Stein H, Hoeft S, De Meester T: Reflux and motility pattern in Barrett's esophagus. Dis Esoph 1992;5:21-28.
66. Stein HJ, Barlow AP, DeMeester TR, Hinder RA: Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35-43.
67. Stein HJ, Esplugues J, Whittle B J, Bauerfeind P, Hinder RA, Blum AL: Direct cytotoxic effect of oxygen radicals on the gastric mucosa. Surgery 1989;106:318-323 (discussion 323-324).
68. Stein HJ, Eypasch EP, DeMeester TR, Smyrk TC, Attwood SE: Circadian esophageal motor function in patients with gastroesophageal reflux disease. Surgery 1990;108:769-777 (discussion 777-778).
69. Stein HJ, Feussner H, Kauer W, DeMeester TR, Siewert JR: Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994;167:163-168.
70. Stein HJ, Hinder RA, Oosthuizen MM: Gastric mucosal injury caused by hemorrhagic shock and reperfusion: protective role of the antioxidant glutathione. Surgery 1990;108:467-473 (discussion 473-474).
71. Stelzner F, Lierse W: The angiomuscular dilation closing of the terminal esophagus. Langenbecks Arch Chir 1968;321:35-64.
72. Taylor PR, Mason RC, Filipe MI, Vaja S, Hanley DC, Murphy GM, Dowling RH, McColl I: Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index. Gut 1991;32:1447-1454.
73. Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-1907.
74. von Ritter C, Hinder RA, Oosthuizen MM, Svensson LG, Hunter SJ, Lambrecht H: Gastric mucosal lesions induced by hemorrhagic shock in baboons. Role of oxygen-derived free radicals. Dig Dis Sci 1988;33:857-864.
75. Wetscher G, Gadenstätter M: Pathophysiology of Gastroesophageal Reflux Disease. Acta Chir Austriaca 1999;31:346-349.
76. Wetscher G, Redmond E, Vitito L: Pathophysiology of gastroesophageal reflux disease. In: Hinder R (ed.): Gastroesophageal reflux disease. Austin, Texas, Medical Intelligence Unit, R.G. Landes Company, 1993, pp 7-29.
77. Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, Glaser K, Hinder RA: Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 1995;18:877-882.
78. Wetscher GJ, Gadenstaetter M, Klingler PJ, Weiss H, Obrist P, Wykypiel H, Klaus A, Profanter C: Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Ann Surg 2001;234:627-632.
79. Wetscher GJ, Glaser K, Gadenstaetter M, Profanter C, Hinder RA: The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. Am J Surg 1999;177:189-192.
80. Wetscher GJ, Glaser K, Wieschemeyer T, Gadenstaetter M, Prommegger R, Profanter C: Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia. World J Surg 1997;21:605-610.
81. Wetscher GJ, Hinder PR, Bagchi D, Perdikis G, Redmond EJ, Glaser K, Adrian TE, Hinder RA: Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995;40:1292-1296.
82. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T: Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995;170:552-556 (discussion 556-557).
83. Wetscher GJ, Hinder RA, Kretchmar D, Stinson R, Perdikis G, Smyrk T, Klingler PJ, Adrian TE: Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996;41:2166-2173.
84. Wetscher GJ, Hinder RA, Perdikis G, Wieschemeier T, Stalzer R: Three-dimensional imaging of the lower esophageal sphincter in healthy subjects and gastroesophageal reflux. Dig Dis Sci 1996;41:2377-2382.
85. Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, Profanter C: Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 1999;44:1132-1135.
86. Wetscher GJ, Perdikis G, Kretchmar DH, Stinson RG, Bagchi D, Redmond EJ, Adrian TE, Hinder RA: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995;40:1297-1305.
87. Wetscher GJ. Profanter C, Gadenstatter M, Perdikis G, Glaser K, Hinder RA: Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility. Langenbecks Arch Chir 1997;382:95-99.
88. Wetscher GJ, Schwelberger H, Unger A, Offner FA, Profanter C, Glaser K, Klingler A, Gadenstaetter M, Klinger P: Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium. Am J Surg 1998;176:569-573.
89. Zaninotto G, Di Mario F, Costantini M, Baffa R, Germana B, Dal Santo PL, Rugge M, Bolzan M, Naccarato R, Ancona E: Oesophagitis and pH of refluxate: an experimental and clinical study. Br J Surg 1992;79:161-164.
90. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg A J: Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391-1399.
91. Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ: Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 1998;273:2424-2428.